Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review
Open Access
- 19 January 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 1264
Abstract
The social burden of dementia is remarkable since it affects some 57.4 million people all over the world. Impairment of autophagy in age-related diseases, such as dementia, deserves deep investigation for the detection of novel disease-modifying approaches. Several drugs belonging to different classes were suggested to be effective in managing Alzheimer’s disease (AD) by means of autophagy induction. Useful autophagy inducers in AD should be endowed with a direct, measurable effect on autophagy, have a safe tolerability profile, and have the capability to cross the blood–brain barrier, at least with poor penetration. According to the PRISMA 2020 recommendations, we propose here a systematic review to appraise the measurable effectiveness of autophagy inducers in the improvement of cognitive decline and neuropsychiatric symptoms in clinical trials and retrospective studies. The systematic search retrieved 3067 records, 10 of which met the eligibility criteria. The outcomes most influenced by the treatment were cognition and executive functioning, pointing at a role for metformin, resveratrol, masitinib and TPI-287, with an overall tolerable safety profile. Differences in sample power, intervention, patients enrolled, assessment, and measure of outcomes prevents generalization of results. Moreover, the domain of behavioral symptoms was found to be less investigated, thus prompting new prospective studies with homogeneous design. PROSPERO registration: CRD42023393456.Keywords
Funding Information
- Phase 2 RIABEO Funding (Executive Decree n.6790 of 22 June 2022) Progetto Ingegno POR Calabria FESR 2014/2020—Azione 1 1 5—Sostegno all’Avanzamento tecnologico delle Imprese Attraverso il Finanziamento di Linee Pilota e Azioni di Validazione Precoce di Pr (NET-2016-02361805 (WP 5), P2022 CJNW, MNESYS (PE0000006))
- Italian Ministry of Health (NET-2016-02361805 (WP 5), P2022 CJNW, MNESYS (PE0000006))
- PRIN 2022 PNRR (NET-2016-02361805 (WP 5), P2022 CJNW, MNESYS (PE0000006))
- #NEXTGENERATIONEU (NGEU) (NET-2016-02361805 (WP 5), P2022 CJNW, MNESYS (PE0000006))
- Ministry of University and Research (MUR) (NET-2016-02361805 (WP 5), P2022 CJNW, MNESYS (PE0000006))
- National Recovery and Resilience Plan (NRRP) (NET-2016-02361805 (WP 5), P2022 CJNW, MNESYS (PE0000006))
This publication has 136 references indexed in Scilit:
- TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer CellsMolecular Cancer Therapeutics, 2012
- Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signalingProceedings of the National Academy of Sciences, 2010
- Novel synthetic small‐molecule activators of AMPK as enhancers of autophagy and amyloid‐β peptide degradationThe FASEB Journal, 2010
- AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide MetabolismJournal of Biological Chemistry, 2010
- Mild Cognitive ImpairmentArchives of Neurology, 2009
- Autophagy and aging: keeping that old broom workingTrends in Genetics, 2008
- Autophagy fights disease through cellular self-digestionNature, 2008
- Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neuronsProceedings of the National Academy of Sciences, 2008
- Autophagic Stress in Neuronal Injury and DiseaseJournal of Neuropathology & Experimental Neurology, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002